Electrophysiologic pattern and prevalence of subclinical peripheral neuropathy in children and adolescents with type I diabetes mellitus in Iran

References

1. ↵
   1. Bluestone JA,
   2. Herold K,
   3. Eisenbarth G

   (2010) Genetics pathogenesis and clinical interventions in type 1 diabetes. Nature 464:1293–1300.
2. ↵
   1. Louraki M,
   2. Karayianni C,
   3. Kanaka-Gantenbein C,
   4. Katsalouli M,
   5. Karavanaki K

   (2012) Peripheral neuropathy in children with type 1 diabetes. Diabetes Metab 38:281–289.
3. ↵
   1. Pasnoor M,
   2. Dimachkie MM,
   3. Kluding P,
   4. Barohn RJ

   (2013) Diabetic neuropathy part1: overview and symmetric phenotypes. Neurol Clin 31:425–445.
4. ↵
   1. Spallone V,
   2. Morganti R,
   3. D'Amato C,
   4. Cacciotti L,
   5. Fedele T,
   6. Maiello MR,
   7. et al.

   (2011) Clinical correlates of painful diabetic neuropathy and relationship of neuropathic pain with sensorimotor and autonomic nerve function. Eur J Pain 15:153–160.
5. ↵
   1. Li G,
   2. Sun C,
   3. Wang Y,
   4. Liu Y,
   5. Gang X,
   6. Gao Y,
   7. et al.

   (2014) A clinical and neuropathological study of Chinese patients with diabetic peripheral neuropathy. PloS One 9:ne91772.
6. ↵
   1. Hasani N,
   2. Khosrawi S,
   3. Hashemipour M,
   4. Haghighatiyan M,
   5. Javdan Z,
   6. Taheri MH,
   7. et al.

   (2013) Prevalence and related risk-factors of peripheral neuropathy in children with insulin-dependent diabetes mellitus. J Res Med Sci 18:132–136.
7. ↵
   1. Won JC,
   2. Kim SS,
   3. Ko KS,
   4. Cha BY

   (2014) Current status of diabetic peripheral neuropathy in Korea: report of a hospital-based study of type 2 diabetic patients in Korea by the diabetic neuropathy study group of the Korean diabetes association. Diabetes Metab J 38:25–31.
8. ↵
   1. Javadzadeh A,
   2. Ghorbanihaghjo A,
   3. Adl FH,
   4. Andalib D,
   5. Khojasteh-Jafari H,
   6. Ghabili K

   (2013) Calcium dobesilate reduces endothelin-1 and high-sensitivity C-reactive protein serum levels in patients with diabetic retinopathy. Mol Vis 19:62–68.
9. ↵
   1. Samahy MH,
   2. Elbarbary NS,
   3. Elmorsi HM

   (2015) Current status of diabetes management, glycemic control and complications in children and adolescents with diabetes in Egypt. Where do we stand now? And where do we go from here? Diabetes Res Clin Pract 107:370–376.
10. ↵
    1. Chiles NS,
    2. Phillips CL,
    3. Volpato S,
    4. Bandinelli S,
    5. Ferrucci L,
    6. Guralnik JM,
    7. et al.

    (2014) Diabetes, peripheral neuropathy, and lower-extremity function. J Diabetes Complications 28:91–95.
11. ↵
    1. Albers JW,
    2. Herman WH,
    3. Pop-Busui R,
    4. Martin CL,
    5. Cleary P,
    6. Waberski B,
    7. et al.

    (2007) Subclinical neuropathy among Diabetes Control and Complications Trial participants without diagnosable neuropathy at trial completion: possible predictors of incident neuropathy? Diabetes Care 30:2613–2618.
12. ↵
    1. Ayromlou H,
    2. Mohammad-Khanli H,
    3. Yazdchi-Marandi M,
    4. Rikhtegar R,
    5. Zarrintan S,
    6. Golzari SE,
    7. et al.

    (2013) Electrodiagnostic evaluation of peripheral nervous system changes in patients with multiple sclerosis. Malays J Med Sci 20:32–38.
13. ↵
    1. Oskouei AE,
    2. Talebi GA,
    3. Shakouri SK,
    4. Ghabili K

    (2014) Effects of neuromobilization maneuver on clinical and electrophysiological measures of patients with carpal tunnel syndrome. J Phys Ther Sci 26:1017–1022.
14. ↵
    1. Gill HK,
    2. Yadav SB,
    3. Ramesh V,
    4. Bhatia E

    (2014) A prospective study of prevalence and association of peripheral neuropathy in Indian patients with newly diagnosed type 2 diabetes mellitus. J Postgrad Med 60:270–275.
15. ↵
    1. Dyck PJ,
    2. Kratz KM,
    3. Karnes JL,
    4. Litchy WJ,
    5. Klein R,
    6. Pach JM,
    7. et al.

    (1993) The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: The Rochester Diabetic Neuropathy Study. Neurology 43:817–824.
16. ↵
    1. Deli G,
    2. Bosnyak E,
    3. Pusch G,
    4. Komoly S,
    5. Feher G

    (2013) Diabetic neuropathies: diagnosis and management. Neuroendocrinology 98:267–280.
17. ↵
    1. Baba M,
    2. Ozaki I

    (2001) Electrophysiological changes in diabetic neuropathy: from subclinical alterations to disabling abnormalities. Arch Physiol Biochem 109:234–240.
18. ↵
    1. Nelson D,
    2. Mah JK,
    3. Adams C,
    4. Hui S,
    5. Crawford S,
    6. Darwish H,
    7. et al.

    (2006) Comparison of conventional and non-invasive techniques for the early identification of diabetic neuropathy in children and adolescents with type 1 diabetes. Pediatr Diabetes 7:305–310.
19. ↵
    1. Madani S,
    2. Larijani B,
    3. Erfani M,
    4. Heshmat R

    (2004) Comparison of clinical evaluation with neurophysiologic findings of sural nerve in the diagnosis of diabetic neuropathy. Iranian Journal of Diabetes and Metabolism 3:89–98.
20. ↵
    1. Soveid M,
    2. Ghavanini M,
    3. Shirdel E,
    4. Omrani G

    (2004) Clinical and electroneurographic of neuropathy in Diabetic patients living in Shiraz. Iranian Journal of Diabetes and Metabolism 3:53–56.
21. ↵
    1. Boulton AJ,
    2. Vinik AI,
    3. Arezzo JC,
    4. Bril V,
    5. Feldman EL,
    6. Freeman R,
    7. et al.

    (2005) Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 28:956–962.
22. ↵
    1. Kiani J,
    2. Moghimbeigi A,
    3. Azizkhani H,
    4. Kosarifard S

    (2013) The prevalence and associated risk factors of peripheral diabetic neuropathy in Hamedan, Iran. Arch Iran Med 16:17–19.
23. ↵
    1. Lee SS,
    2. Han HS,
    3. Kim H

    (2010) A 5-yr follow-up nerve conduction study for the detection of subclinical diabetic neuropathy in children with newly diagnosed insulin-dependent diabetes mellitus. Pediatr Diabetes 11:521–528.
24. ↵
    1. Jaiswal M,
    2. Lauer A,
    3. Martin CL,
    4. Bell RA,
    5. Divers J,
    6. Dabelea D,
    7. et al.

    (2013) Peripheral neuropathy in adolescents and young adults with type 1 and type 2 diabetes from the SEARCH for Diabetes in Youth follow-up cohort: a pilot study. Diabetes Care 36:3903–3908.
25. ↵
    1. Karsidag S,
    2. Morali S,
    3. Sargin M,
    4. Salman S,
    5. Karsidag K,
    6. Us O

    (2005) The electrophysiological findings of subclinical neuropathy in patients with recently diagnosed type 1 diabetes mellitus. Diabetes Res Clin Pract 67:211–219.
26. 1. Meh D,
    2. Denislic M

    (1998) Subclinical neuropathy in type I diabetic children. Electroencephalogr Clin Neurophysiol 109:274–280.
27. ↵
    1. Karavanaki K,
    2. Baum JD

    (1999) Prevalence of microvascular and neurologic abnormalities in a population of diabetic children. J Pediatr Endocrinol Metab 12:411–422.
28. ↵
    1. Bao XH,
    2. Wong V,
    3. Wang Q,
    4. Low LC

    (1999) Prevalence of peripheral neuropathy with insulin-dependent diabetes mellitus. Pediatr Neurol 20:204–209.
29. ↵
    1. Deshpande AD,
    2. Harris-Hayes M,
    3. Schootman M

    (2008) Epidemiology of diabetes and diabetes-related complications. Phys Ther 88:1254–1264.
30. ↵
    1. Smith AG,
    2. Ramachandran P,
    3. Tripp S,
    4. Singleton JR

    (2001) Epidermal nerve innervation in impaired glucose tolerance and diabetes-associated neuropathy. Neurology 57:1701–1704.
31. ↵
    1. Kikkawa Y,
    2. Kuwabara S,
    3. Misawa S,
    4. Tamura N,
    5. Kitano Y,
    6. Ogawara K,
    7. et al.

    (2005) The acute effects of glycemic control on nerve conduction in human diabetics. Clin Neurophysiol 116:270–274.
32. ↵
    1. Parano E,
    2. Uncini A,
    3. De Vivo DC,
    4. Lovelace RE

    (1993) Electrophysiologic correlates of peripheral nervous system maturation in infancy and childhood. J Child Neurol 8:336–338.